These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37569634)

  • 21. Protein Arginine Methyltransferase 1-Dependent Labeling and Isolation of Histone H4 through N-Mustard Analogues of S-Adenosyl-l-methionine.
    Hymbaugh SJ; Pecor LM; Tracy CM; Comstock LR
    Chembiochem; 2019 Feb; 20(3):379-384. PubMed ID: 30427579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo.
    Herrmann F; Lee J; Bedford MT; Fackelmayer FO
    J Biol Chem; 2005 Nov; 280(45):38005-10. PubMed ID: 16159886
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PRMT1 expression is elevated in head and neck cancer and inhibition of protein arginine methylation by adenosine dialdehyde or PRMT1 knockdown downregulates proliferation and migration of oral cancer cells.
    Chuang CY; Chang CP; Lee YJ; Lin WL; Chang WW; Wu JS; Cheng YW; Lee H; Li C
    Oncol Rep; 2017 Aug; 38(2):1115-1123. PubMed ID: 28656289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A protein arginine N-methyltransferase 1 (PRMT1) and 2 heteromeric interaction increases PRMT1 enzymatic activity.
    Pak ML; Lakowski TM; Thomas D; Vhuiyan MI; Hüsecken K; Frankel A
    Biochemistry; 2011 Sep; 50(38):8226-40. PubMed ID: 21851090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling.
    Yao B; Gui T; Zeng X; Deng Y; Wang Z; Wang Y; Yang D; Li Q; Xu P; Hu R; Li X; Chen B; Wang J; Zen K; Li H; Davis MJ; Herold MJ; Pan HF; Jiang ZW; Huang DCS; Liu M; Ju J; Zhao Q
    Genome Med; 2021 Apr; 13(1):58. PubMed ID: 33853662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLAR
    Li M; An W; Xu L; Lin Y; Su L; Liu X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):64. PubMed ID: 30736843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding protein arginine methyltransferase 1 (PRMT1) product specificity from molecular dynamics.
    Gathiaka S; Boykin B; Cáceres T; Hevel JM; Acevedo O
    Bioorg Med Chem; 2016 Oct; 24(20):4949-4960. PubMed ID: 27545444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PRMT1-mediated arginine methylation of PIAS1 regulates STAT1 signaling.
    Weber S; Maass F; Schuemann M; Krause E; Suske G; Bauer UM
    Genes Dev; 2009 Jan; 23(1):118-32. PubMed ID: 19136629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein-arginine methyltransferase 1 suppresses megakaryocytic differentiation via modulation of the p38 MAPK pathway in K562 cells.
    Chang YI; Hua WK; Yao CL; Hwang SM; Hung YC; Kuan CJ; Leou JS; Lin WJ
    J Biol Chem; 2010 Jul; 285(27):20595-606. PubMed ID: 20442406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.
    Eberhardt A; Hansen JN; Koster J; Lotta LT; Wang S; Livingstone E; Qian K; Valentijn LJ; Zheng YG; Schor NF; Li X
    Oncotarget; 2016 Sep; 7(39):63629-63639. PubMed ID: 27571165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PRMT1 promotes mitosis of cancer cells through arginine methylation of INCENP.
    Deng X; Von Keudell G; Suzuki T; Dohmae N; Nakakido M; Piao L; Yoshioka Y; Nakamura Y; Hamamoto R
    Oncotarget; 2015 Nov; 6(34):35173-82. PubMed ID: 26460953
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transcriptional repression of hypoxia-inducible factor-1 (HIF-1) by the protein arginine methyltransferase PRMT1.
    Lafleur VN; Richard S; Richard DE
    Mol Biol Cell; 2014 Mar; 25(6):925-35. PubMed ID: 24451260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PRMT1 Is Recruited via DNA-PK to Chromatin Where It Sustains the Senescence-Associated Secretory Phenotype in Response to Cisplatin.
    Musiani D; Giambruno R; Massignani E; Ippolito MR; Maniaci M; Jammula S; Manganaro D; Cuomo A; Nicosia L; Pasini D; Bonaldi T
    Cell Rep; 2020 Jan; 30(4):1208-1222.e9. PubMed ID: 31995759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-mustard analogs of S-adenosyl-L-methionine as biochemical probes of protein arginine methylation.
    Hymbaugh Bergman SJ; Comstock LR
    Bioorg Med Chem; 2015 Aug; 23(15):5050-5055. PubMed ID: 26037613
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of PRMT1-mediated arginine methylation on the subcellular localization, stress granules, and detergent-insoluble aggregates of FUS/TLS.
    Yamaguchi A; Kitajo K
    PLoS One; 2012; 7(11):e49267. PubMed ID: 23152885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRMT1 promotes pancreatic cancer growth and predicts poor prognosis.
    Song C; Chen T; He L; Ma N; Li JA; Rong YF; Fang Y; Liu M; Xie D; Lou W
    Cell Oncol (Dordr); 2020 Feb; 43(1):51-62. PubMed ID: 31520395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nη-substituted arginyl peptide inhibitors of protein arginine N-methyltransferases.
    Lakowski TM; 't Hart P; Ahern CA; Martin NI; Frankel A
    ACS Chem Biol; 2010 Nov; 5(11):1053-63. PubMed ID: 20701328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Constitutive high expression of protein arginine methyltransferase 1 in asthmatic airway smooth muscle cells is caused by reduced microRNA-19a expression and leads to enhanced remodeling.
    Sun Q; Liu L; Wang H; Mandal J; Khan P; Hostettler KE; Stolz D; Tamm M; Molino A; Lardinois D; Lu S; Roth M
    J Allergy Clin Immunol; 2017 Aug; 140(2):510-524.e3. PubMed ID: 28081849
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arginine methylation of BCL-2 antagonist of cell death (BAD) counteracts its phosphorylation and inactivation by Akt.
    Sakamaki J; Daitoku H; Ueno K; Hagiwara A; Yamagata K; Fukamizu A
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6085-90. PubMed ID: 21444773
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients.
    Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H
    Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.